当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3806419
自主品牌
已选条件
-
T1832Walrycin B；化合物Walrycin BWalrycin B
Walrycin B is a new-type antibacterial compound targeting the WalR response regulator.
价 格：￥电议型 号：T1832产 地：中国大陆
-
T18319MC-Val-Cit-PAB-Auristatin E；化合物 T18319MC-Val-Cit-PAB-Auristatin E
MC-Val-Cit-PAB-Auristatin E is an antibody-drug conjugate (ADC) linker compound featuring Auristatin E, a potent cytotoxic tubulin modifier, connected through the MC-Val-Cit-PAB linker, exhibiting significant antitumor activity.
价 格：￥电议型 号：T18319产 地：中国大陆
-
T18318MC-Val-Ala-PAB-PNP；化合物MC-Val-Ala-PAB-PNPinhibit|||ADC Linkers|||Inhibitor|||MC Val Ala PAB PNP|||Ant
MC-Val-Ala-PAB-PNP is a cleavable ADC linker. MC-Val-Ala-PAB-PNP can be used in the synthesis of antibody-drug conjugates (ADCs).
价 格：￥电议型 号：T18318产 地：中国大陆
-
T18317MCC-Modified Daunorubicinol；化合物 T18317MCC-Modified Daunorubicinol
Daunorubicinol, a potent antitumor drug-linker conjugate for antibody-drug conjugate (ADC) applications, utilizes Aur0101 (DNA Topoisomerase II inhibitor) connected through the ADC linker[1].
价 格：￥电议型 号：T18317产 地：中国大陆
-
T18316MC-Sq-Cit-PAB-Gefitinib；化合物 T18316MC-Sq-Cit-PAB-Gefitinib
MC-Sq-Cit-PAB-Gefitinib is a potent antitumor drug-linker conjugate for Antibody-Drug Conjugates (ADC), utilizing Gefitinib—an EGFR tyrosine kinase inhibitor—connected through the MC-Sq-Cit-PAB ADC linker.
价 格：￥电议型 号：T18316产 地：中国大陆
-
T18315MC-Sq-Cit-PAB-Dolastatin10；化合物 T18315MC-Sq-Cit-PAB-Dolastatin10
MC-Sq-Cit-PAB-Dolastatin10 is a potent antitumor drug-linker conjugate for Antibody-Drug Conjugates (ADC), utilizing Dolastatin10 (a tubulin polymerization inhibitor) connected through the MC-Sq-Cit-PAB ADC linker.
价 格：￥电议型 号：T18315产 地：中国大陆
-
T18314MC-PEG2-C2-?NHS ester；化合物 T18314MC-PEG2-C2-?NHS ester
MC-PEG2-C2-NHS ester, a noncleavable 2-unit polyethylene glycol (PEG) linker, is employed in the synthesis of antibody-drug conjugates (ADCs).
价 格：￥电议型 号：T18314产 地：中国大陆
-
T18313Mc-O-Si(di-iso)-Cl；化合物 T18313Mc-O-Si(di-iso)-Cl
Mc-O-Si(di-iso)-Cl is a cleavable ADC linker, commonly employed in the synthesis of antibody-drug conjugates (ADCs) like Gemcitabine-O-Si(di-iso)-O-Mc [1].
价 格：￥电议型 号：T18313产 地：中国大陆
-
T18312Mc-MMAE；马来酰亚胺基己酰-单甲基澳瑞他汀 EMaleimidocaproyl-monomethylauristatin E；Maleimidocaproyl-monomethylaurista
Mc-MMAE (Maleimidocaproyl-monomethylauristatin E) is a drug-linker conjugate for ADC. Mc-MMAE is a maleimidocaproyl-conjugated monomethyl auristatin E, which is a potent tubulin inhibitor.
价 格：￥电议型 号：T18312产 地：中国大陆
-
T18311Mc-MMAD；化合物 T18311Mc-MMAD
Mc-MMAD, a drug-linker conjugate for antibody-drug conjugates (ADCs), incorporates the protective group maleimidocaproyl (Mc) conjugated to monomethyl auristatin D (MMAD), a potent inhibitor of tubulin.
价 格：￥电议型 号：T18311产 地：中国大陆
-
T18310AZ1508；化合物 T18310MC-Lys-MMETA；MC-Lys-MMETA
AZ1508, a tubulin inhibitor[1], serves as a drug-linker conjugate for antibody-drug conjugates (ADC) targeting breast and stomach cancer treatment.
价 格：￥电议型 号：T18310产 地：中国大陆
-
T1831StemRegenin 1；化合物StemRegenin 1SR1；SR1
StemRegenin 1 (SR1) is an aryl hydrocarbon receptor (AhR) inhibitor.
价 格：￥电议型 号：T1831产 地：中国大陆
-
T18309Mc-Leu-Gly-Arg；化合物 T18309Mc-Leu-Gly-Arg
Mc-Leu-Gly-Arg is a cleavable ether linker for antibody-drug conjugates (ADC) design.
价 格：￥电议型 号：T18309产 地：中国大陆
-
T18308MC-Gly-Gly-Phe；化合物MC-Gly-Gly-PheMC-Gly-Gly-Phe
MC-Gly-Gly-Phe is a cleavable linker. MC-Gly-Gly-Phe can be used for antibody-drug conjugates (ADC).
价 格：￥电议型 号：T18308产 地：中国大陆
-
T18307MC(C5)-Val-Cit；化合物 T18307MC(C5)-Val-Cit
MC(C5)-Val-Cit is a cleavable ADC linker employed in ADCs synthesis [1].
价 格：￥电议型 号：T18307产 地：中国大陆
-
T18306MC-Alkyl-Hydrazine Modified MMAF；化合物 T18306MC-Alkyl-Hydrazine Modified MMAF
MC-Alkyl-Hydrazine Modified MMAF is a potent antitumor drug-linker conjugate for ADC, incorporating Modified MMAF, a tubulin inhibitor, through a noncleavable MC-Alkyl-Hydrazine linkage[1].
价 格：￥电议型 号：T18306产 地：中国大陆
-
T18305Mal-VC-PAB-DM1；化合物 T18305Mal-VC-PAB-DM1
Mal-VC-PAB-DM1, a drug-linker conjugate for antibody-drug conjugates (ADCs), exhibits potent antitumor activity. It incorporates DM1, a potent microtubule-disrupting agent, connected through the ADC linker Mal-VC-PAB [1].
价 格：￥电议型 号：T18305产 地：中国大陆
-
T18304Mal-VC-PAB-ABAEP-Azonafide；化合物 T18304Mal-VC-PAB-ABAEP-Azonafide|||MalVCPABABAEPAzonafide|||Mal VC PA
Mal-VC-PAB-ABAEP-Azonafide, an ADC (antibody-drug conjugate) linker-drug conjugate, demonstrates potent antitumor activity. It incorporates Azonafide, a cytotoxin, connected through the ADC linker Mal-VC-PAB[1].
价 格：￥电议型 号：T18304产 地：中国大陆
-
T18303Mal-Phe-C4-VC-PAB-MMAE；化合物 T18303Mal-Phe-C-4-VC-PAB-MMAE|||Mal Phe C4 VC PAB MMAE|||Mal-Phe-C4-VC-PA
Mal-Phe-C4-VC-PAB-MMAE is a chemical compound resulting from the conjugation of monomethyl auristatin E (MMAE), a potent tubulin inhibitor serving as a toxin payload in antibody-drug conjugates, with a Mal-Phe-C4-VC-PAB linker.
价 格：￥电议型 号：T18303产 地：中国大陆
-
T18302Mal-Phe-C4-VC-PAB-DMEA-PNU-159682；化合物 T18302Mal Phe C4 VC PAB DMEA PNU 159682|||Mal-Phe-C4-VC-PAB-DM
Mal-Phe-C4-VC-PAB-DMEA-PNU-159682 is a drug-linker conjugate utilized in antibody-drug conjugate (ADC) therapy. It comprises the ADC linker Mal-Phe-C4-VC-PAB and the potent ADC cytotoxin DMEA-PNU-159682. DMEA-PNU-159682 encompasses metabolites of nemorubicin (MMDX) derived from liver microsomes, as well as the ADC cytotoxin PNU-159682[1].
价 格：￥电议型 号：T18302产 地：中国大陆
